دورية أكاديمية
Cost of childhood cancer treatment in Ethiopia.
| العنوان: | Cost of childhood cancer treatment in Ethiopia. |
|---|---|
| المؤلفون: | Mirutse MK; Department of Global Public Health and Primary Care, Bergen Centre for Ethics and Priority Setting (BCEPS), University of Bergen, Bergen, Norway.; Ministry of Health Ethiopia, Addis Ababa, Ethiopia., Palm MT; Clinton Health Access Initiative, Addis Ababa, Ethiopia., Tolla MT; Department of Global Public Health and Primary Care, Bergen Centre for Ethics and Priority Setting (BCEPS), University of Bergen, Bergen, Norway., Memirie ST; Department of Global Public Health and Primary Care, Bergen Centre for Ethics and Priority Setting (BCEPS), University of Bergen, Bergen, Norway.; Addis Center for Ethics and Priority Setting, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia., Kefyalew ES; Clinton Health Access Initiative, Addis Ababa, Ethiopia., Hailu D; Department of Pediatrics and Child Health, Pediatric Hematology/Oncology Unit, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia., Norheim OF; Department of Global Public Health and Primary Care, Bergen Centre for Ethics and Priority Setting (BCEPS), University of Bergen, Bergen, Norway.; Department of Global Health and Population, Harvard T.H. Chan School of Public Health, Boston, MA, United States of America. |
| المصدر: | PloS one [PLoS One] 2023 Jun 02; Vol. 18 (6), pp. e0286461. Date of Electronic Publication: 2023 Jun 02 (Print Publication: 2023). |
| نوع المنشور: | Journal Article; Research Support, Non-U.S. Gov't |
| اللغة: | English |
| بيانات الدورية: | Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE |
| أسماء مطبوعة: | Original Publication: San Francisco, CA : Public Library of Science |
| مواضيع طبية MeSH: | Neoplasms*/therapy, Humans ; Child ; Adolescent ; Ethiopia/epidemiology ; Delivery of Health Care ; Health Services ; Cost Sharing ; Health Care Costs |
| مستخلص: | Background: Despite the recent interest in expanding pediatric oncology units in Ethiopia, reflected in the National Childhood and Adolescent Cancer Control Plan (NCACCP), little is known about the cost of running a pediatric oncology unit and treating childhood cancers. Methods: We collected historical cost data and quantity of services provided for the pediatric oncology unit and all other departments in Tikur Anbessa Specialized Hospital (TASH) from 8 July 2018 to 7 July 2019, using a provider perspective and mixed (top-down and bottom-up) costing approaches. Direct costs (human resources, drugs, supplies, medical equipment) of the pediatric oncology unit, costs at other relevant clinical departments, and overhead cost share are summed up to estimate the total annual cost of running the unit. Further, unit costs were estimated at specific childhood cancer levels. Results: The estimated annual total cost of running a pediatric oncology unit was USD 776,060 (equivalent to USD 577 per treated child). The cost of running a pediatric oncology unit per treated child ranged from USD 469 to USD 1,085, on the scenario-based sensitivity analysis. Drugs and supplies, and human resources accounted for 33% and 27% of the total cost, respectively. Outpatient department and inpatient department shared 37% and 63% of the cost, respectively. For the pediatric oncology unit, the cost per OPD visit, cost per bed day, and cost per episode of hospital admission were USD 36.9, 39.9, and 373.3, respectively. The annual cost per treated child ranged from USD 322 to USD 1,313 for the specific childhood cancers. Conclusion: Running a pediatric oncology unit in Ethiopia is likely to be affordable. Further analysis of cost effectiveness, equity, and financial risk protection impacts of investing in childhood cancer programs could better inform the prioritization of childhood cancer control interventions in the Ethiopia Essential Health Service Package. Competing Interests: The authors have declared that no competing interests exist. (Copyright: © 2023 Mirutse et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.) |
| References: | Health Policy Plan. 2020 Oct 1;35(8):1003-1010. (PMID: 32772112) J Clin Oncol. 2015 Sep 20;33(27):3065-73. (PMID: 26304881) Lancet. 2004 Dec 11-17;364(9451):2097-105. (PMID: 15589307) J Clin Oncol. 2010 May 20;28(15):2625-34. (PMID: 20404250) Lancet Oncol. 2013 Mar;14(3):e95-e103. (PMID: 23434338) Cancer. 2014 Aug 15;120(16):2388-91. (PMID: 24853582) Lancet Oncol. 2013 Mar;14(3):e104-16. (PMID: 23434340) BMJ Glob Health. 2019 Oct 31;4(5):e001825. (PMID: 31749998) J Glob Oncol. 2018 Nov;4:1-7. (PMID: 30433841) Cancer. 2019 Jun 1;125(11):1918-1928. (PMID: 30840316) Semin Pediatr Surg. 2012 May;21(2):136-41. (PMID: 22475119) BMC Res Notes. 2015 Sep 24;8:474. (PMID: 26404043) Cancer Med. 2020 Sep;9(18):6802-6812. (PMID: 32697427) J Glob Oncol. 2018 Sep;4:1-11. (PMID: 30241262) Curr Opin Pediatr. 2013 Feb;25(1):3-15. (PMID: 23295716) Lancet Glob Health. 2021 Dec;9(12):e1750-e1757. (PMID: 34756183) Lancet Oncol. 2018 Dec;19(12):1590-1601. (PMID: 30416076) Cancer. 2021 Mar 1;127(5):787-793. (PMID: 33108002) J Glob Oncol. 2018 Sep;4:1-9. (PMID: 30241273) Pediatr Blood Cancer. 2016 Mar;63(3):387-91. (PMID: 26797891) Afr J Paediatr Surg. 2009 Jul-Dec;6(2):126-30. (PMID: 19661650) |
| تواريخ الأحداث: | Date Created: 20230602 Date Completed: 20230605 Latest Revision: 20230620 |
| رمز التحديث: | 20240628 |
| مُعرف محوري في PubMed: | PMC10237368 |
| DOI: | 10.1371/journal.pone.0286461 |
| PMID: | 37267276 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder | تدمد: | 1932-6203 |
|---|---|
| DOI: | 10.1371/journal.pone.0286461 |